USWM CT, LLC

Industry · 8 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Recruiting	SPEARHEAD-3 Pediatric Study Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma (NBL)	Phase 1 / Phase 2	2023-09-01
Active Not Recruiting	ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Ca Ovarian Cancer	Phase 2	2023-06-26
Active Not Recruiting	Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/ Neoplasms	Phase 2	2019-12-31
Active Not Recruiting	Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Neoplasms	Phase 2	2019-12-31
Active Not Recruiting	ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With M Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ)	Phase 1	2019-08-20
Active Not Recruiting	Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Synovial Sarcoma, Myxoid Liposarcoma	Phase 2	2019-08-13
Recruiting	Adoptive Cell Therapy Long-term Follow-up (LTFU) Study Neoplasms	Phase 1	2018-04-09
Available	Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel Synovial Sarcoma, Myxoid Liposarcoma	—	—